In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418
- 1 May 1996
- journal article
- Published by Elsevier in Brain Research
- Vol. 719 (1-2) , 36-44
- https://doi.org/10.1016/0006-8993(96)00063-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Nicotine Enhancement of Fast Excitatory Synaptic Transmission in CNS by Presynaptic ReceptorsScience, 1995
- Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's DiseaseCNS Drug Reviews, 1995
- Functional expression of nicotinic acetylcholine receptors containing rat α7 subunits in human SH‐SY5Y neuroblastoma cellsFEBS Letters, 1994
- α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cellsCell, 1994
- Cloning and sequence of the human ?7 nicotinic acetylcholine receptorDrug Development Research, 1993
- The Diversity of Neuronal Nicotinic Acetylcholine ReceptorsAnnual Review of Neuroscience, 1993
- Pharmacological properties of the homomeric α7 receptorNeuroscience Letters, 1992
- Nicotine, Parkinson's and Alzheimer's DiseaseReviews in the Neurosciences, 1992
- A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTXNeuron, 1990